| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 05/18/2006 | WO2006052807A2 A dna molecule of mortierella alpina lpaat homolog |
| 05/18/2006 | WO2006052754A2 Ammonium transporter promoter for gene expression in oleaginous yeast |
| 05/18/2006 | WO2006052148A1 Process for preparing a bacterial culture, and the product prepared by the process |
| 05/18/2006 | WO2006051944A1 Fluorescent protein |
| 05/18/2006 | WO2006051871A1 Method of treating water containing microcystin and apparatus therefor |
| 05/18/2006 | WO2006051660A1 Method of producing l-amino acid |
| 05/18/2006 | WO2006051418A2 Transcription factor of the zn binuclear cluster family of fungal regulators |
| 05/18/2006 | WO2006051387A1 Method of producing a carnitine-synthesising micro-organism |
| 05/18/2006 | WO2006050625A2 Method for removing bacteria from a fermentation broth |
| 05/18/2006 | WO2006018446A3 Method to improve lactococcus preservation |
| 05/18/2006 | WO2005010170A3 Fermentation medium based on a highly hydrolized protein substrate |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2004072238A3 Terminal-phosphate-labeled nucleotides with new linkers |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060107337 Elimination of endogenous porcine retrovirus |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106120 Method of degrading plastic and process for producing useful substance using the same |
| 05/18/2006 | US20060105914 Plant wall degradative compounds and systems |
| 05/18/2006 | US20060105446 Biodegradable, resistant to nitrate salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 05/18/2006 | US20060105442 Promoters and proteins from Clostridium thermocellum and uses thereof |
| 05/18/2006 | US20060105436 Immunosuppressant selected from prolyl-rapamycin, 4-hydroxy-prolyl-rapamycin, 4-hydroxyprolyl-26-demethoxy-rapamycin, 3-hydroxy-prolyl-rapamycin, 3-hydroxy-prolyl-26-demethoxy-rapamycin, and trans-3-aza-bicyclo[3,1,0]hexane-2-carboxylic acid rapamycin |
| 05/18/2006 | US20060105432 Method for the production of vitamin b12 |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105428 Alkaline protease |
| 05/18/2006 | US20060105427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/18/2006 | US20060105425 Aspergillus niger promoter for expressing genes in host cells |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105389 Solubilizing inclusion bodies in a detergent to release the ScFv antibody; oxidizing to form disulfide bonds; removing the detergent;precipitating the oxidized ScFv antibodies; dissolving the precipitated ScFv antibodies in a denaturing solution; immobilizing on solid support; renaturing, elution |
| 05/18/2006 | US20060105372 Compositions and methods for purifying nucleic acids from stabilization reagents |
| 05/18/2006 | US20060105361 Donor yeast strain for transfer of genetic material |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105326 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
| 05/18/2006 | US20060104996 Methods for producing oocysts |
| 05/18/2006 | US20060104991 Methods for constructing antibiotic resistance free vaccines |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104955 Radiation therapy by accumulation of therapeutic radionuclides in tumor-targeting bacteria |
| 05/18/2006 | US20060104949 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | DE19810349B4 Chitindeacetylasegen, Vektor, der dieses Gen enthält und Transformanten Chitindeacetylasegen, vector containing this gene and transformants |
| 05/18/2006 | CA2586988A1 Process for preparing a bacterial culture, and the product prepared by the process |
| 05/18/2006 | CA2585404A1 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | CA2585235A1 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | CA2584719A1 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/17/2006 | EP1657313A2 Methods and reagents for preserving RNA in cell and tissue samples |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1657252A2 PGC-1, a novel brown fat PPAR gamma coactivator |
| 05/17/2006 | EP1657251A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/17/2006 | EP1656455A2 Process for the purification of recombinant polypeptides |
| 05/17/2006 | EP1656445A1 A method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof |
| 05/17/2006 | EP1656444A2 Fermentation medium based on a highly hydrolized protein substrate |
| 05/17/2006 | EP1656443A2 Solid phase cell lysis and capture platform |
| 05/17/2006 | EP1656222A1 Abiogenic transition unit |
| 05/17/2006 | EP1656149A1 Sealing of bacterial ghosts by means of bioaffinity interactions |
| 05/17/2006 | EP1656025A2 A stable liquid probiotic composition, preparation and applications thereof |
| 05/17/2006 | EP1325126B1 Human ion-exchanger proteins and polynucleotides encoding the same |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1141368B1 Method for producing ascorbic acid intermediates |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP0990024B1 Use of lactobacillus for reduction of the fibrinogen level in blood |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 05/17/2006 | EP0831148B1 Human adhesion molecule occludin |
| 05/17/2006 | EP0796273B1 Variants of human papilloma virus antigens |
| 05/17/2006 | CN1774512A Screening method for genes of brewing yeast |
| 05/17/2006 | CN1774505A Candida utilis containing gamma-glutamylcysteine |
| 05/17/2006 | CN1774501A Implement and method for freezing and storing egg |
| 05/17/2006 | CN1772907A Purified polyporus laccases and nucleic acids encoding same |
| 05/17/2006 | CN1772905A Recombinant organophosphate degrading enzyme gene and its expression vector and prepn process |
| 05/17/2006 | CN1772903A New-type froctosan saccharase gene and its use |
| 05/17/2006 | CN1772881A Fluorescent pseudomonads and its fermenting culture process and application |
| 05/17/2006 | CN1772880A Agricultural waste fermenting bacterial prepn and its prepn process |
| 05/17/2006 | CN1772879A Sewage and sludge fermentation process of producing biopesticide bacillus thuringiensis |
| 05/17/2006 | CN1772878A Cellar mud caproic acid bacteria culturing techn |
| 05/17/2006 | CN1772877A Continuous flow culture method of industrial biological hydrogen preparing spawn and biological hydrogen preparing system reinforcing method |
| 05/17/2006 | CN1772876A Formulation of aweto culture medium and oxygenating culture method of aweto |
| 05/17/2006 | CN1772875A Application of preserved spirulina |
| 05/17/2006 | CN1771831A Feed level microbe additive and its prepn and application |
| 05/17/2006 | CN1256591C HCV antigen/antibody combination assay |
| 05/17/2006 | CN1256440C Microbial preparation of substances from aromatic metabolism/I |
| 05/17/2006 | CN1256425C Sea micromonoad antibiotic active substance fermentation promoter |
| 05/17/2006 | CN1256424C 'Yuanjiang' black spore fungus |
| 05/16/2006 | US7045683 Δ4-desaturase genes and uses thereof |
| 05/16/2006 | US7045675 Protein for use in the diagnosis and detection of Niemann-Pick disease |
| 05/16/2006 | US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 05/16/2006 | US7045614 LIM mineralization protein splice variants |
| 05/16/2006 | US7045613 IKK-αproteins, nucleic acids and methods |
| 05/16/2006 | US7045612 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer |
| 05/16/2006 | US7045611 Nucleic acid molecule, comprising a nucleic acid coding for a polypeptide with chorismate mutase activity |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045602 Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045595 For development of therapeutic drugs for diseases associated with immunity or hematopoiesis |
| 05/16/2006 | US7045593 Using detergents; antiagglomerants; eukaryotic membrane protein |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |